Membrane contact sites (MCS) between organelles are proposed as nexuses for the exchange of lipids, small molecules, and other signals crucial to cellular function and homeostasis. Various protein complexes, such as the endoplasmic reticulum-mitochondrial encounter structure (ERMES), function as dynamic molecular tethers between organelles. Here, we report the reconstitution and characterization of subcomplexes formed by the cytoplasm-exposed synaptotagmin-like mitochondrial lipid-binding protein (SMP) domains present in three of the five ERMES subunits-the soluble protein Mdm12, the endoplasmic reticulum (ER)-resident membrane protein Mmm1, and the mitochondrial membrane protein Mdm34. SMP domains are conserved lipid-binding domains found exclusively in proteins at MCS. We show that the SMP domains of Mdm12 and Mmm1 associate into a tight heterotetramer with equimolecular stoichiometry. Our 17-Å-resolution EM structure of the complex reveals an elongated crescent-shaped particle in which two Mdm12 subunits occupy symmetric but distal positions at the opposite ends of a central ER-anchored Mmm1 homodimer. Rigid body fitting of homology models of these SMP domains in the density maps reveals a distinctive extended tubular structure likely traversed by a hydrophobic tunnel. Furthermore, these two SMP domains bind phospholipids and display a strong preference for phosphatidylcholines, a class of phospholipids whose exchange between the ER and mitochondria is essential. Last, we show that the three SMP-containing ERMES subunits form a ternary complex in which Mdm12 bridges Mmm1 to Mdm34. Our findings highlight roles for SMP domains in ERMES assembly and phospholipid binding and suggest a structure-based mechanism for the facilitated transport of phospholipids between organelles.
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interorganelle tether | phospholipid exchange | membrane contact sites | membrane protein complex | electron microscopy E ukaryotic cells comprise a complex and interconnected network of membrane-bound organelles. Although this remarkable cellular compartmentalization enables the efficient segregation of diverse metabolic processes, the membranes that envelop these organelles impose a physical barrier impeding the exchange of molecules. To overcome this problem, eukaryotic cells exploit membrane contact sites (MCS), or regions of proximity between two organelles, for the transfer and exchange of cellular signals (1, 2) .
With the exception of the endoplasmic reticulum (ER), all organelles lack the biochemical machinery necessary to synthesize a full complement of their phospholipids (3) (4) (5) . This situation imposes a requirement for interorganelle phospholipid exchange for the biogenesis of organelles, with the principal exporter of these molecules being the ER. Although most organelles obtain their lipids through vesicular trafficking, others, such as mitochondria, are not connected to such pathways and therefore obtain their lipids by nonvesicular mechanisms. Physical connections between the ER and mitochondria at sites called "mitochondria-associated membranes" (MAMs) have been implicated in the nonvesicular transport of lipids (6) . However, the molecular mechanisms that govern transport at MAMs are largely unresolved. Growing evidence points to a prospective role for interorganelle tethering complexes in the exchange of phospholipids at MCS (1, 7) . These tethers typically comprise soluble and membrane proteins that reside on the surface of the ER and the associated organelle. For contact sites with mitochondria, a multisubunit complex called the "endoplasmic reticulum-mitochondrial encounter structure" (ERMES) has been shown to provide a bridge to the ER in the yeast Saccharomyces cerevisiae. The ERMES comprises the soluble protein Mdm12, the ER-resident membrane protein Mmm1, two outer mitochondrial membrane proteins, Mdm10 and Mdm34 (8) , and the mitochondrial regulatory Miro GTPase Gem1 ( Fig.  1A) (9, 10) .
The biosynthesis of aminoglycerophospholipids requires the extensive exchange of phospholipid precursors between the ER and mitochondria (5) . As depicted in Fig. 1B and Fig. S1 , the synthesis of phosphatidylcholine (PC) in the ER requires the transport of phosphatidylserine (PS) from the ER to mitochondria to synthesize phosphatidylethanolamine (PE), after which PE is transported back to the ER to produce PC. In the absence of ERMES, the conversion of PS to PC was shown to be impaired (8) . Although other studies reported no noticeable change in the conversion of PS to PE (11, 12) , these results potentially can be explained by additional cellular mechanisms for phospholipid exchange that can compensate for ERMES Significance Phospholipid exchange between the endoplasmic reticulum (ER) and mitochondria is essential for membrane biogenesis and, ultimately, cell survival. It remains unclear, however, how this exchange is facilitated. Our study investigates a putative involvement of the ER-mitochondrial encounter structure (ERMES), a tethering complex that bridges the ER and mitochondria, in phospholipid transport in yeast. We show that a conserved ERMES domain called the "synaptotagmin-like mitochondrial lipid-binding protein" (SMP) domain preferentially binds phosphatidylcholines and mediates the hierarchical assembly of the tether. The 17-Å-resolution EM structure of the complex formed between the SMP domains present in two ERMES subunits, Mdm12 and Mmm1, reveals an elongated, tubular-shaped heterotetramer traversed by a hydrophobic channel, suggesting a mechanism for lipid transport between the two organelles.
function. Consistent with this possibility, two recent studies (13, 14) have identified a second complex called the "vacuole and mitochondria patch" (vCLAMP) that bridges the vacuole and mitochondria, potentially alleviating the loss of ERMES by importing ER-derived lipids from the vacuole to mitochondria. The absence of one causes expansion of the other, whereas the elimination of both is lethal. To date, the direct involvement of ERMES in phospholipid exchange remains inconclusive.
A unique feature of ERMES is the presence of a synaptotagmin-like mitochondrial lipid-binding protein (SMP) domain in three of its five subunits: Mdm12, Mmm1, and Mdm34 ( Fig.  1A ) (15) (16) (17) . Although the function of the SMP domain is not fully understood, emerging evidence suggests a potential role in lipid transport. SMP-containing proteins are localized predominantly at contact sites between the ER and other organelles (18) . They belong to the tubular lipid-binding protein (TULIP) superfamily comprising known lipid-binding proteins such as Takeout (19) , the bactericidal/permeability-increasing protein (BPI) (20) , the cholesteryl ester transfer protein (CETP) (21) , and the lipopolysaccharide-binding protein (LBP) (22) . The crystal structure of the SMP domain of the human extended synaptotagmin 2 protein (E-SYT2) was determined recently (23) , revealing its tubular structure with a hydrophobic tunnel occupied by a phospholipid (Fig. 1C) . These structural features resemble other TULIP proteins, suggesting that the SMP do-main has a conserved physiological role in phospholipid binding and transport.
Important advances have been made in establishing the importance of ERMES in membrane tethering. However, we still lack basic knowledge of how the structural properties of ERMES constituents (i.e., subunit structure and stoichiometry) are related to the function of the complex. To help bridge this gap, we combined computational modeling, analytical biochemistry, MS, quantitative lipidomics, and EM to elucidate the role of the conserved SMP domain as a key component of ERMES. Here, we report the first structure, to our knowledge, of a subcomplex of ERMES, revealing a unique mode of assembly between the SMP domains of Mdm12 and Mmm1. We also demonstrate that Mdm12 bridges Mmm1 and Mdm34, providing a structural basis for membrane tethering. Last, the SMP domain binds phospholipids, supporting the direct involvement of ERMES in phospholipid exchange. Our results lay the groundwork for future structural and functional dissections of ERMES and other interorganelle tethering complexes in yeast and mammals.
Results

Homology Modeling and Sequence Analysis of the SMP Domains of
Mdm12 and Mmm1 Reveal Conserved Folds and Surfaces. In yeast, Mdm12 is a soluble protein, and Mmm1 is an ER membrane protein with an N-terminal glycosylated luminal extension, a single transmembrane α-helix, and a large cytoplasmic C-terminal domain. Previous bioinformatics studies predict that the SMP domain of Mdm12 spans the full-length protein (residues M1-E271), and that of Mmm1 maps to its C terminus at residues E196-P409 (16, 17) . On the other hand, the SMP domain of Mdm34 is N-terminal and is followed by a region predicted to be disordered and presumably involved in the association with the outer mitochondrial membrane ( Fig. S2 A and B) . Based on this prediction, we considered the full-length Mdm12 and an SMPcontaining fragment of Mmm1 (residues K162-L426, termed "Mmm1Δ5") for modeling with Phyre 2 (SI Experimental Procedures) (24) . Comparative homology modeling of the two SMP domains using structures of proteins in the Protein Data Bank (PDB) identified the SMP domain of human E-SYT2 (23) as the best template; other members of the TULIP superfamily, including BPI, CETP, and LBP, also were identified as suitable templates.
The SMP domain of E-SYT2 forms a dimer in which each monomeric unit comprises an incomplete, but highly twisted, seven-stranded β-barrel and three helices (α1, α2, and α3), with α2 partially capping one end of the barrel (Fig. 1C ). Like all TULIP proteins, the internal lipid-binding cavity of E-SYT2 is lined with hydrophobic residues. Despite the overall low sequence identity (∼16-18%) between E-SYT2 and Mdm12 or Mmm1Δ5, the two ERMES proteins were modeled with greater than 90% confidence (Fig. S3 ). The two models closely resemble the E-SYT2 structure; the core rmsd between the SMP model of Mdm12 or Mmm1 and the template E-SYT2 crystal structure is ∼1 Å (Figs. 1C and 2A and Fig. S3A ). The elongated feature of these models is particularly pronounced in the case of Mdm12; in both Mdm12 and Mmm1 the internal cavity is lined with hydrophobic residues and has dimensions, geometries, and chemical properties compatible with the binding of hydrophobic ligands such as phospholipids ( Fig. 2B ).
Next, we analyzed the amino acid sequence conservation of Mdm12 or Mmm1 by multiple sequence alignments using 21 fungal and five nonfungal orthologs in organisms in which a full complement of ERMES proteins had been annotated (25) . The resulting scores were mapped to the protein surfaces of our homology models using ConSurf (26) (SI Experimental Procedures) to highlight conserved structural features of the two proteins. This comprehensive analysis revealed two conserved surfaces near residues S2-W7 and N142-F148 of Mdm12 and two conserved surfaces near residues E196-N202-Q207 and R373-L376-K381 of Mmm1. The conserved regions appeared to be located on the opposite ends ("head" and "tail") of the elongated, tubular-shaped SMP domains (Figs. S3A and S4A). Because the SMP domain of E-SYT2 forms a homodimer, we also modeled the corresponding assemblies in Mmm1 and Mdm12. Our analysis suggests that the SMP domain of Mmm1 displays structural features compatible with the formation of a similar homodimer ( Fig. S4B ). In such a configuration, the two 45-Å-long tubular SMP domains would associate head-to-head to form a 90-Å-long cylinder.
The SMP Domains of Mdm12 and Mmm1 Form a Tight Heterotetramer with Equimolecular Stoichiometry. We hypothesized that the cytoplasm-exposed SMP domains of ERMES subunits mediate their assembly into a molecular tether. To test this, we explored the propensity for complex formation by the SMP domains of Mdm12 and Mmm1. Based on previous bioinformatics predictions (16) and our homology models, we proceeded to isolate a soluble SMP-containing fragment of Mmm1 using a systematic deletion strategy by which eight deletion constructs (termed "Mmm1Δ1" through "Mmm1Δ8") ( Fig. S2A ) that mapped along the cytoplasmic-exposed region of Mmm1 were generated. The Mmm1Δ1 construct encoded the full cytoplasmic domain (S122-L426) of Mmm1, whereas Mmm1Δ2 to Mmm1Δ8 encoded truncated variants in which 10 amino acids were successively deleted from the N terminus of Mmm1Δ1. The constructs displayed varied levels of expression and solubility when expressed and purified from Escherichia coli. However, these levels improved substantially when the proteins were fused at their N termini to a thrombin-cleavable, maltose-binding protein (MBP-Mmm1Δ1−Δ8).
Unlike the other constructs, Mmm1Δ8 remained largely insoluble with no improvement in solubility when fused to MBP.
Next, we tested for complex formation by coexpressing full-length Mdm12 with three MBP-Mmm1 constructs: MBP-Mmm1Δ1, MBP-Mmm1Δ5, and MBP-Mmm1Δ7 (Fig. 3A) . The resultant fusion complexes were isolated by affinity chromatography using the His 6 tag on Mmm1 (Mdm12 was not tagged). Subsequent purification by size-exclusion chromatography (SEC) revealed the formation of a stable and monodisperse complex for all three combinations tested ( Fig. 3 B and C and Fig. S5A ). Upon treatment with thrombin, we observed the quantitative release of the MBP tag, but the resultant complex severed from MBP remained intact. When we coexpressed Mdm12 and Mmm1Δ5 lacking the MBP tag, we observed an identical complex eluting at the same position on SEC as the Mdm12/Mmm1Δ5 severed from MBP ( Fig. 3 B and C and Fig. S5A ), suggesting that the MBP did not alter the oligomeric assembly of the complex.
We explored the possibility that the solubility, or rather the overall stability, of Mmm1Δ8 might be enhanced by the presence of Mdm12. Thus, we coexpressed Mmm1Δ8 (with or without an MBP tag) and Mdm12. We did not observe the formation of a stable and monodisperse complex, suggesting that Mmm1Δ7 contains the minimal structural elements required for Mmm1 interaction with Mdm12.
We proceeded to determine the stoichiometry of the Mdm12/ Mmm1Δ5 complex using SEC coupled to multiangle static light scattering (SEC-MALS), a technique for determining the absolute molar mass of macromolecules in solution (SI Experimental Procedures). Our analysis revealed that Mdm12 is a monomer with a mass of ∼31 kDa ( Fig. 3D ), whereas Mdm12/Mmm1Δ5 forms a complex with a mass of ∼133 kDa, compatible ( Fig. 3D ) with a tetrameric arrangement (calculated mass ∼125 kDa). Given the similar molecular mass of Mdm12 and Mmm1Δ5 (∼31.2 kDa), we resolved the ambiguity in subunit stoichiometry by determining the mass of the same complex fused to MBP (MBP-Mmm1Δ5/Mdm12) to be ∼210 kDa ( Fig. 3E) ; the increase in mass by ∼77 kDa compared with the MBP-free complex corresponded to the addition of two molecules of MBP (calculated mass ∼41.2 kDa), suggesting that Mdm12 and Mmm1 form a heterotetramer with 2:2 stoichiometry. SEC-MALS also revealed that MBP-Mmm1Δ5 forms dimers ( Fig. 3D) ; because MBP is a monomer in solution, the observed dimer could only be the result of interactions between SMP domains, as is consistent with our homology models.
Taken together, our systematic truncation and coexpression strategies enabled the identification and reconstitution of a minimalistic complex of Mdm12/Mmm1 that is mediated by their SMP domains. Most importantly, we observed that Mdm12/Mmm1Δ1, the full cytoplasmic portion of Mdm12/Mmm1, behaves identically to Mdm12/Mmm1Δ5 or Mdm12/Mmm1Δ7 complexes, demonstrating that amino acids 122-181 are not essential for complex formation (Fig. S5B ). To assemble the complex, a dimer of Mmm1 recruits two monomers of Mdm12.
Mdm12 Acts as a Bridge Between Mmm1 and Mdm34. Having established the existence of a stable subcomplex between the SMP domains of Mdm12 and Mmm1, we investigated the role of the SMP domain of Mdm34 (hereafter termed "Mdm34-SMP") in the assembly of the tether. We expressed Mdm34-SMP (a 22-kDa protein) fused to GFP or GST at its N terminus (GFP is purely monomeric, whereas GST is dimeric) (SI Experimental Procedures and Fig. S2A ). The purified fusion proteins eluted at the same position on SEC, suggesting that Mdm34-SMP is a dimer (Fig.  4A ). Consistently, Mdm34-SMP generated by controlled intracellular proteolytic processing (SI Experimental Procedures) purifies as a dimer on SEC. Previous studies have shown that full-length Mdm34 coimmunoprecipitates with all ERMES components (9, 27) . However, the hierarchy of interactions between ERMES subunits and how these interactions are mediated has never been characterized. To study these interactions in detail, we performed pull-downs using purified His-tagged Mdm34-SMP as bait against Mdm12, the SMP domain of Mmm1 (Mmm1Δ5), or the Mdm12/ Mmm1Δ5 complex ( Fig. 4B ). Although Mdm34-SMP interacted with Mdm12 and the Mdm12/Mmm1Δ5 complex, we did not detect any interaction with Mmm1Δ5, suggesting that Mdm12 bridges the SMP domains of Mmm1 and Mdm34. Attempts to stabilize the ternary complex to define its stoichiometry were unsuccessful, likely because of the weak association between Mdm34-SMP and the Mdm12/Mmm1 complex and the propensity of Mdm34-SMP to aggregate. Within ERMES, Mdm34 and Mmm1 are the only SMP-containing subunits that are membrane anchored; based on our biochemical data, we can propose several models of SMP assemblies that could support apposition of membranes (Fig. 4C ). The simplest model predicts that two monomers of Mdm12 would bridge the dimers of Mdm34 and Mmm1 (model 1 in Fig. 4C ); another possibility would consist of two dimers of Mdm34, each contacting one of the two monomers of Mdm12 associated with the Mmm1 dimer (model 2 in Fig. 4C ). Last, in a more sophisticated model, a dimer of Mdm34 would engage two monomers of Mdm12 projecting from two different and adjacent Mmm1 dimers (model 3 in Fig. 4C ); this model could explain the observation that in yeast hundreds of ERMES molecules concentrate in punctate structures (8, 28) . Although different, each of the resulting SMP assemblies would display some level of symmetry.
The SMP Domains of Mdm12 and Mmm1 Bind Phospholipids. Given the extensive lipid exchange that occurs between the ER and mitochondria and the identification of a phospholipid molecule bound to the SMP domain of E-SYT2, we hypothesized that the SMP-containing subunits of ERMES also may bind phospholipids. To test this hypothesis, Mdm12, Mmm1Δ1, Mmm1Δ5, and their corresponding reconstituted complexes were expressed in E. coli, extensively purified to remove any unbound or weakly associated lipid contaminants, and analyzed by quantitative electrospray ionization MS (ESI-MS) and high-performance TLC (HPTLC) for bound phospholipids (SI Experimental Procedures).
MS analysis under nondenaturing conditions (native-MS) of Mdm12 purified from E. coli revealed the presence of a predominantly ligand-bound form with a mass-to-charge ratio (m/z) of 2,653 for charge state +12 and an apo form at an m/z of 2,588 ( Fig. 5A ). Deconvolution of the spectrum indicated an average difference in mass of ∼703-781 Da between the ligand-bound form (∼31,850 Da) and the apo form (∼31,069 Da) of Mdm12, suggesting the presence of a singly-bound molecule of phospholipid per protein ( Fig. 5A , Inset).
To confirm this result, the bound lipids were extracted and analyzed by HPTLC. We identified PE and phosphatidylglycerol (PG) as the primary phospholipids copurifying with Mdm12 ( Fig.  5B ). The molecular identities of these lipids were characterized further by quantitative ESI-MS. Of the bound lipids, 80% were PE species [the most prominent of which is PE (33:1) with an m/z of 704.5], and 15% were PG species [the main one being PG (34:1) with an m/z of 766.5] ( Fig. S6 A and B and Table S1 ). The ratio of bound PE to bound PG is consistent with previous lipidomic analyses of bacterial membranes (29) and with our own quantification of total bacterial PE (∼85%) and PG (∼10%) levels ( Fig. S6A ). Correspondingly, we observed the copurification of PE and PG with Mmm1Δ1, Mmm1Δ5, and the corresponding Mdm12/Mmm1 complexes ( Fig. 5B and Fig. S5B ). Thus, like Mdm12, the SMP domain of Mmm1 and the reconstituted Mdm12/Mmm1 complexes bound bacterial PE and PG.
A previous bioinformatics and MS-based study demonstrated that ERMES also is present in eukaryotic lineages outside Fungi (25) . Thus, we proceeded to corroborate our findings in S. cerevisiae by investigating the phospholipid-binding properties of Mdm12 in the closely related Saccharomyces castellii and the more distantly related amoeba, Dictyostelium discoideum. Proteins were expressed in E. coli (SI Experimental Procedures) and analyzed by HPTLC. Binding to bacterial PE and PG was observed in Mdm12 from both species (Fig. 6A ). So far the limited stability of the Mdm34-SMP prevents the thorough characterization of its lipidbinding properties; nevertheless, sufficient evidence on other SMPcontaining proteins strongly supports the possibility that Mdm34 also could bind phospholipids.
Taken together, our data strongly suggest that phospholipid binding is an evolutionarily conserved feature of the SMP domain and therefore implicate ERMES in the direct exchange of phospholipids between the ER and mitochondria.
Mdm12 and Mmm1 Preferentially Bind Phosphatidylcholines. In an attempt to determine the identity of a native phospholipid ligand of Mdm12 or Mmm1, we first tested the ability of purified phospholipids to displace a fluorescently labeled PE, 7-nitrobenz-2-oxa-1,3-diazol-4-yl-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (NBD)-PE, preloaded in Mdm12 purified from E. coli (SI Experimental Procedures and Fig. 5C ). The same approach was used to characterize the phospholipid-binding properties of E-SYT2 (23) . The phospholipids tested here have fatty acid chain lengths of 16-18 carbons and critical micelle concentrations (CMCs) estimated to be in the nanomolar range. To ensure that the competing phospholipids did not aggregate, we performed this assay in the presence of the detergent lauryldimethylamine-oxide (LDAO). LDAO was chosen for its ability to enhance NBD-PE preloading (presumably by reducing phospholipid aggregation) and its inability to displace NBD-PE already bound to Mdm12 (Fig. S7 ). We observed an ∼2.7 fold increase in NBD-PE loading in the presence of LDAO at 0.2 mM, twice its CMC compared with the control without detergent ( Fig. 5C and Fig. S7A ). Importantly, when we incubated Mdm12 already preloaded with NBD-PE with the same concentration of LDAO, a minimum displacement (less than 10%) was observed ( Fig. 5C and Fig. S7B ). Other detergents, such as 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and lysofoscholine-10 (LFC10), were efficient in NBD-PE loading ( Fig. S7 A-C); however, when mixed with the purified phospholipids the resulting mixed micelles adversely altered protein migration on blue native PAGE (BN-PAGE). Therefore LDAO was selected as the best candidate.
Mixed micelles containing one given phospholipid (present in 18-molar excess relative to Mdm12) and the noncompeting detergent LDAO (at 0.2 mM final concentration) then were used to examine the phospholipid-binding preference of Mdm12. PE, PC, and PG robustly displaced NBD-PE from Mdm12, achieving 93, 94, and 95% displacement, respectively, as evidenced by the loss of fluorescence in the band corresponding to Mdm12 on BN-PAGE ( Fig. 5C ). Conversely, we observed moderate displacement (∼27%) by phosphatidylinositol (PI) and almost no displacement (less than 5%) by PA, PS, and cardiolipin ( Fig. 5C ). Given the ability of phospholipids to partition into a complex phase composed of free phospholipid, micelles, aggregates, and also mixed micelles in the presence of detergent, it is not possible to quantify the binding affinity between Mdm12 and phospholipids accurately. Phospholipids remain bound to the recombinant proteins despite extensive purification (i.e., four to five chromatographic steps), suggesting a relatively high binding affinity. PE, PC, PG, and, to a lesser extent, PI bind to Mdm12, but PA, PS, and cardiolipin (CL) do not. In nonphotosynthetic eukaryotes, such as yeast and mammals, PG is synthesized only in the inner mitochondrial membrane where it is used as a precursor for cardiolipin biosynthesis (4, 5). The nearly complete displacement observed for PG is puzzling, because its reported cellular localization precludes contact with Mdm12 and other ERMES components. However, all the other lipids are accessible to binding by ERMES subunits based on their distribution in ER and outer mitochondrial membranes (30) . Based on the E-SYT2 structure, the SMP domain of Mdm12 probably interacts primarily with the acyl chains of phospholipids. Our data indeed demonstrate that Mdm12 promiscuously binds some glycerophospholipids but also highlight its ability to discriminate against others. These results suggest the presence of cryptic determinants for selective lipid recognition.
In parallel with the lipid displacement assay described above, we sought to identify the bona fide endogenous ligand of the SMP domain by analyzing the lipids bound to Mdm12 purified from yeast, its native host ( Fig. 6A ). HPTLC revealed the presence of PC and likely a mixture of PE and PI (which comigrate on the TLC plate). We confirmed this finding by ESI-MS, which revealed the presence of PC (60%), PI (23%), PE (10.5%), and a small amount of PS (3%) ( Fig. 6B ). PC is absent in most bacterial species, including E. coli (29) , explaining why it was not detected in our previous experiments. The total cellular phospholipid levels present in yeast containing overexpressed levels of Mdm12 are very similar to previously reported yeast phospholipid levels (31-34). Interestingly, bound PC (60%) is enriched by at least twofold compared with its natural abundance (∼27%). This observation is consistent with the results of our lipid-displacement assay and thus raises the strong possibility that PC might be the main endogenous ligand of Mdm12. The molecular identities of the bound PC species were determined also ( Fig. 6B, Fig. S6C , and Table S1 ); the most prominent species detected was PC (32:2) with an m/z of 730.5. Despite the strong affinity of PG for Mdm12 observed in our displacement assays, yeast-purified Mdm12 was not enriched for PG ( Fig. 6 A and B ), suggesting that Mdm12 does not bind PG in vivo. Last, we proceeded to identify the endogenous ligand of Mmm1 and the Mdm12/Mmm1 complex by incubating E. colipurified MBP-Mmm1Δ5 or Mdm12/Mmm1Δ5 complex with liposomes prepared with yeast phospholipids (SI Experimental Procedures and Fig. 6C ). As a positive control, we carried out the same analysis using Mdm12 alone. The use of purified liposomes with defined compositions greatly reduces the possibility of Mdm12 or Mmm1 binding freely existing phospholipid monomers. Here, to bind phospholipids, the proteins must extract them physically from the bilayer environment of the liposomes. HPTLC analysis of lipids extracted from the MBP-Mmm1Δ5 and Mdm12/Mmm1 complex protein samples before and after incubation with liposomes revealed PC and PI displacement of bacterial PE and PG, consistent with our lipid-profiling data on Mdm12 (Fig. 6C ). Although we observed PI binding to both proteins in this liposome assay, the lack of enrichment in Mdm12 purified from yeast suggests it might not be the main ligand of Mdm12.
Our results from four different experimental approaches show that the SMP domains of Mdm12 and Mmm1are genuine lipidbinding proteins with a preference for phosphatidylcholines. Reconstituted Mdm12/Mmm1Δ5 and Mdm12/Mmm1Δ1 complexes were examined by negative staining EM (SI Experimental Procedures). Class averages of negatively stained particles for both complexes revealed similar elongated, crescent-shaped particles in high homogeneity ( Fig. 7A and Fig. S8 A and B) . To obtain the 3D structures of these complexes, we first performed 3D reconstruction of the Mdm12/Mmm1Δ5 complex using the random conical tilt (RCT) method ( Fig. S8E) (35) , which can generate 3D maps from tilt-pair images without the need of an initial 3D model. The RCT 3D reconstruction of the Mdm12/ Mmm1Δ5 complex yielded an EM map at 35-Å resolution ( Fig.  7D and Fig. S8D ) that displayed structural features consistent with the class averages. Interestingly, even though no symmetry was applied during the 3D reconstruction, the EM map shows strong features of twofold rotational symmetry. Next, we reconstructed the 3D EM map of the Mdm12/Mmm1Δ1 complex to 17-Å resolution from negatively stained particle images using the aforementioned RCT 3D EM map of the Mdm12/ Mmm1Δ5 complex as the initial model and with a twofold symmetry applied ( Fig. 7E and Fig. S8D ). Except for the difference in resolution, the reconstructions obtained the two complexes are highly similar, indicating that the two complexes adopt a relatively homogeneous and similar architecture and conformation ( Fig. 7 D and E). Overall, the Mdm12/Mmm1 complex is crescent-shaped and exhibits twofold symmetry. With dimensions of ∼210 × 45 × 35 Å along the three major axes, anisotropy is the most salient structural feature of the complex.
To locate the positions of both Mdm12 and Mmm1 subunits within the 3D structures, we also imaged the complexes with either an MBP tag on the N terminus of Mmm1Δ5 or a GFP tag on the C terminus of Mdm12 (Figs. 3C and 7 B and C and Fig. S8C ). Class averages of the tagged complexes clearly revealed additional structures corresponding to either two MBP or two GFP molecules. These findings corroborated the stoichiometry of the complex that we determined biochemically and provided novel structural insights into the spatial organization of Mdm12 and Mmm1Δ5, in which two Mdm12 molecules bind either end of a central Mmm1Δ5 homodimer to form an extended and overall crescent-shaped complex. For the Mdm12/MBP-Mmm1Δ1 complex, although raw particle images show the densities corresponding to each MBP, their density is blurred out after class averaging, thus indicating that they occupy different positions and suggesting that the linker region (S122-L181) in Mmm1 is flexible and contributes little, if any, to the overall architecture of the complex.
The resulting EM maps were used for fitting the crystal structure of the E-SYT2 SMP domain. The E-SYT2 SMP dimer (Fig. 1C ) was fitted in the central module of the EM structure to model the Mmm1 homodimer, and two E-SYT2 SMP monomers were adjusted separately to model the two distal copies of Mdm12 bound at the symmetric ends of the Mmm1 dimer ( Fig. 7 F and G and Movie S1). We also used our homology models of the Mmm1 homodimer ( Fig. S4B ) and the Mdm12 monomer (Fig. 1C) to generate a corresponding pseudoatomic homology model (Movie S2) of the ERMES Mdm12/Mmm1 complex. In our models, the positions of the C terminus of Mdm12 and N terminus of Mmm1 agree with the relative positions of the MBP or GFP based on class averages of the fusion complexes (Fig.  S9 ). Our models also predict a tail-to-head arrangement at the Mmm1-to-Mdm12 interface (Fig. S3) where the SMP domains of Mmm1 and Mdm12 interact through conserved surfaces located at their extremities in agreement with our surface conservation analyses (Fig. S4A) . In our EM structure, the four tubular SMP domains are nearly aligned; the phospholipid binding cavities present in each SMP domain could rearrange to create one large and quasi-continuous hydrophobic tunnel for channeling lipids between the ER and mitochondria.
Discussion
Our study reveals two important properties of the SMP domains of ERMES: They bind to phospholipids and mediate the physical interactions between Mmm1, Mdm12, and Mdm34. The identification of lipids bound to the SMP domains of Mdm12, Mmm1, and orthologs of Mdm12 that include the distantly related amoeba Dictyostelium suggests a conserved physiological lipidbinding role of SMP-containing proteins that is not yet fully understood. One attractive hypothesis that explains the current findings is that these proteins function as lipid transfer proteins (LTP). This hypothesis is supported by the structural similarities of the SMP to proteins in the TULIP superfamily, several of which participate in lipid transfer (21, 36) . Moreover, the presence of SMP-containing proteins at ER-mitochondria contact sites (16, 37) , which are highly enriched in lipid-synthesizing enzymes (6), strongly supports a role for ERMES in the transfer of lipids.
We demonstrate that the SMP domains of Mdm12 and Mmm1 are capable of binding different glycerophospholipids. Interestingly, the analysis of lipids extracted from Mdm12 purified directly from its native host yeast demonstrated that there was substantial enrichment of PC compared with other phospholipids. Consistently, when Mdm12 or the SMP domain of Mmm1 purified from E. coli was incubated with liposomes prepared with yeast phospholipids, it was evident that PC, and to some extent PI, strongly displaced bacterial PE and PG. PC is the most abundant mitochondrial phospholipid, but it is synthesized primarily in the ER (38) . The involvement of MAMs in PC import into mitochondria has not been established. Our findings demonstrate that PC might be the main physiological ligand of Mdm12 and Mmm1. Thus, it is attractive to hypothesize that ERMES facilitates this essential transport. The possibility that the observed lipid-binding preferences might change in the context of a fully assembled tether has not been completely dismissed. These findings provide novel insights into the role of the SMP domain in the hierarchical assembly of the ERMES tether. Mdm12 was shown to play a central role in bridging the SMP domains of Mmm1 and Mdm34, providing a rationale for the previous observation that Mdm12 displays dual membrane localization. In the absence of Mdm34, Mdm12 is localized to the ER; however, in the absence of Mmm1, Mdm12 is localized to mitochondria (8) . The interaction between Mdm12 and Mdm34 based on our pull-down assay is relatively weak compared with the interaction observed between Mdm12 and Mmm1. This result is not entirely unexpected for two possible reasons: (i) Because of the highly dynamic nature of the ER and mitochondria, a tightly associated tether might be physiologically unfavorable; (ii) it is conceivable that the regulatory subunit of ERMES, the Ca 2+ -binding Miro GTPase Gem1, plays a regulatory role in modulating the binding interactions of the three ERMES subunits. In support of this hypothesis, Gem1 has been demonstrated to regulate ERMES organization directly, and its deletion alters the size and number of intracellular ERMES (10) .
In addition to ERMES, other interorganelle-tethering complexes have been shown to consist of SMP-containing proteins. For example, tricalbins 1, 2, and 3, which are yeast homologs of the human E-SYTs, tether the ER and plasma membrane in yeast (39) . Also, the nucleus-vacuole junction 2 protein (Nvj2p) is enriched at the nucleus-vacuole junction (18) , and likely bridges the two organelles. Therefore it is attractive to speculate that the SMP domain might act as a general scaffold to facilitate protein-protein interactions that enable tether formation, resulting in the juxtaposition of organelles at MCS.
The 17-Å-resolution EM reconstruction of the Mdm12/Mmm1 complex revealed a 210-Å-long elongated, crescent-shaped assembly, in which a central Mmm1 dimer is flanked by two molecules of Mdm12 that project outwards. The dimer of Mmm1 is connected to its ER transmembrane anchor by a 50-to 70-residue-long flexible linker that could span a distance of 160 Å in a fully extended conformation ( Fig. 8A and Fig. S9A ). Homology models of the two proteins fitted into the EM density suggested the formation of an extended, tubular-shaped tunnel formed upon alignment of four SMP domains; each SMP harbors a hydrophobic interior for binding phospholipids. Based upon this information, we propose a comprehensive model of ERMES wherein the Mdm12/Mmm1 complex (which lies parallel to the plane of the ER membrane) associates with the dimerizationprone SMP domain of Mdm34 attached to the outer mitochondrial membrane ( Fig. 8A and Fig. S9A ). This arrangement places Mdm12 in a central bridging position (Fig. 4C) . The flexible linkers that connect the SMPs of Mmm1 and Mdm34 to their respective membranes provide the necessary flexibility that can enable movement of the core assembly of the SMPs (Fig.  8B ). In this organization, the interaction of all three proteins can easily accommodate the reported distance of ∼15-30 nm between organelles at MCS (40) . However, the precise stoichiometry of a fully assembled tether remains unknown.
Currently, a mechanism for phospholipid exchange between the ER and mitochondria remains largely undefined. Given its location at ER-mitochondria junctions and the established role of its SMP domains in phospholipid binding, ERMES is very likely to facilitate such an exchange actively. Two examples of lipid transport systems that occur via nonvesicular mechanisms help explain how a complex such as ERMES could exchange lipids while, at the same time, tethering organelles. In the first example, the steroidogenic acute regulatory protein (STARD11) has been shown to tether the ER and Golgi apparatus via its Golgi membrane-associated pleckstrin homology domain and FFAT motif (two phenylalanines in an acidic tract) bound to the ER vesicle-associated membrane-associated protein (VAP) (41, 42) . This membrane-tethering arrangement has been shown to allow the lipid-binding START domain of STARD11 to transfer ceramide from the ER to Golgi in a swing-like mechanism. The second example involves the STARD3 protein that recently has been proposed to tether the ER and the late endosome and enable the exchange of cholesterol between the two organelles (43) .
The crystal structure of E-SYT2 suggested two mechanisms of SMP-mediated phospholipid transport (23): (i) a tunnel model, wherein the elongated dimer of aligned SMP domains (Fig. 1C ) bridges the two membranes and functions as a conduit to transport lipids; and (ii) a tethered shuttle model in which the SMP dimer shuttles between membranes, extracting lipids from one and delivering them to the other. The lateral opening along the side of the SMP β-barrel, a conserved feature of all TULIP proteins, might facilitate phospholipid transfer by maintaining the exposure of the polar head group to the solvent while nesting the fatty acid tails within the hydrophobic tunnel (Fig. 8C ). Translocation systems that process diverse types of substrates such as nascent proteins (44, 45) and lipids (46) often use a lateral opening (referred to as the "lateral gate" or "seam") to partition their substrate between a proteinaceous binding pocket and a membrane. Such a system could facilitate the extraction and exchange of lipids from membranes or, in a more sophisticated model, the sliding of lipids from one SMP domain to another in the aligned configuration ( Fig. 8D) .
A model based on the tunnel model of E-SYT2 was proposed recently to explain how ERMES might facilitate lipid transport: Lang et al. (47) speculated that individual monomers of Mmm1 interact directly with Mdm34 or Mdm12 to form heterodimeric tunnels that run between the ER and mitochondria. However, our biochemical and structural data do not support the formation of such tunnels. Instead, we propose a model for transport in which the core Mmm1/Mdm12/Mdm34 assembly of SMPs partitions phospholipids from membranes and shuttles them back and forth between the ER and mitochondria (Fig. 8B ). Diffusion is both controlled and facilitated by the flexible tethers on both membranes. In this aspect, our model is similar to the tethered shuttle elaborated by Schauder et al (23) . This model is in contrast to oxysterol-binding homology protein 6 (Osh6), a different class of LTP that acts as a freely diffusible cytosolic shuttle capable of extracting PS from the ER and delivering it to the plasma membrane (48) . Although the kinetics and detailed molecular mechanisms of lipid transport by ERMES remain to be elucidated, one possibility is that the net transfer of lipids likely depends on their concentration gradients. In this scenario, the enrichment of PC in the ER (the donor membrane), where it is synthesized, drives its transport to the primary site of use in mitochondria (the acceptor membrane). Indeed, the PC-transfer protein and the PI-transfer protein have been reported previously to facilitate lipid exchange in a similar fashion (49) .
One feature that distinguishes the ERMES from E-SYT2 is that the ERMES requires multiple subunits to bridge two organelles (i.e., Mdm12 in the cytoplasm, Mmm1 on the ER, and Mdm34 on the mitochondrion), whereas E-SYT2 singly tethers ER and plasma membranes. Why would transfer of PC (or another phospholipid) require such elaborate machinery? The presence of proteins on both organelles could impart specificity, provide additional layers of regulation, and increase the efficiency of lipid transport. Future goals include the reconstitution of all five ERMES components to dissect rigorously the dynamic mechanisms that underlie membrane tethering and phospholipid exchange at ER-mitochondrial contact sites.
To the best of our knowledge, our work provides the first detailed biochemical and structural analyses of ERMES. Furthermore, the present combined data inform a model for how the SMP domains Mdm12 and Mmm1 SMP domains were modeled in Phyre 2 . The quality of the corresponding models is evaluated using the confidence and percentage of sequence identity estimated for each template PDB structure used to model the target protein. For confidence greater than 90%, one generally can be very confident that the query protein adopts the overall fold shown and that the core of the protein is modeled at high accuracy (2-to 4-Å rmsd from the native, true structure). However, surface loops probably will deviate from the native structure. The percentage of sequence identity between the target sequence and the PDB template determines the likely accuracy of the model. For extremely high-accuracy models, numbers should be above 30-40%. However, even at very low sequence identities (<15%) models can be meaningful and useful as long as the confidence is high. Results are summarized in Fig. S3B . For Sce-Mdm12, we also constructed a pRSF vector to express Sce-Mdm12 fused to a superfolder GFP at its C terminus followed by a His tag (sfGFP-His). In this case the sfGFP carrier cannot be severed from Mdm12, but the His tag that follows can; this construct was used for crystallization trials and electron microscopy. Mmm1 expression constructs in E. coli. Eight deletion constructs mapping to the cytoplasmic domain of Sce-Mmm1 were generated through systematic deletion by 10-residue increments start-ing at the N terminus of the predicted cytoplasmic domain of Sce-Mmm1. These different constructs were cloned in a pRSF vector with an N-terminal MBP carrier protein and a C-terminal His tag. Construct Mmm1Δ1 (residues 122-426) encompasses the entire cytoplasmic domain. Construct Mmm1Δ5 (residues 181-426) encompasses the SMP domain that was modeled in Phyre 2 and used for most of the biochemical and structural work. Construct Mmm1Δ7 (residues 201-426) encompasses the SMP domain stricto senso. Residues 1-100 and 101-121 correspond to the short glycosylated luminal domain and the single transmembranespanning helix, respectively (Fig. S2A ). Mdm34 expression constructs in E. coli. Three deletion constructs mapping to the predicted cytoplasmic SMP domain of Sce-Mdm34 were generated starting at the N terminus. These different constructs were cloned in a pGEX-4T1 (ampicillin resistance) vector with an N-terminal GST carrier protein and a C-terminal His tag. The same constructs were cloned in a pRSF vector with an N-terminal GFP fusion protein and a C-terminal His tag. Construct Mdm34 SMP1 (residues 1-188) encompasses the SMP domain and was used for biochemical characterization (characterization on its own and in association with Mdm12 and Mmm1 by pull-down) and lipid analysis (Fig. S2B) . A specific construct was generated consisting of GST fused to Mdm34 SMP1-His with a tobacco etch virus (TEV) protease cleavage site introduced between GST and the SMP, and the protein was cleaved in vivo by coexpressing the GST-tev-Mdm34 SMP-His protein with a plasmid producing TEV protease (2) . The Mdm34 SMP domain was severed from its GST partner by TEV protease in vivo and purified using the His tag. Constructs for Mdm12/Mmm1 coexpression and copurification. Mdm12/ Mmm1 complexes were coexpressed by cotransformation of two vectors in the same cells, because the alternative strategy based on the use of a single plasmid containing both Mdm12 and Mmm1 genes proved less effective. Preliminary expression tests indicated that coexpression was limited by the amount of Mmm1 efficiently produced in E. coli, whereas Mdm12 appeared to be in large excess. Thus the Mdm12 protein was expressed with a C-terminal Flag peptide tag, and the different Mmm1 constructs were expressed as MBP-fusion proteins carrying a C-terminal His tag (Fig. S2C) . Bacterial heterologous expression. Expression and purification of the abovementioned proteins were performed using the following protocol. E. coli C43 (DE3) cells were transformed with one or two plasmids for single or coexpression tests, respectively. Freshly transformed cells were used to inoculate an overnight preculture of LB broth medium at 37°C. The next day, 3-6 L of LB were inoculated with preculture and grown at 37°C to an optical density at 600 nm of 0.5-0.8, at which point the temperature was lowered to 20°C for 1 h. Protein expression then was induced by adding isopropyl-β-D-thiogalactoside (IPTG) at 0. and lyophilized. The resulting material was dissolved in 30 μL of methanol and loaded onto a silica gel 60 HPTLC plate (10 × 10 cm) (Merck). Plates were developed sequentially, first with a phase composed of dichloromethane:ethyl-acetate:acetone (80:16:4) and then with a phase composed of chloroform:acetone:isopropanol: ethyl-acetate:ethanol:methanol:water: acetic acid (30:6:6:6:16:28:6:2) (6). The plates were vacuum-dried, dripped in a 10% (wt/vol) CuSO 4 solution in 8% (vol/vol) aqueous phosphoric acid, and charred at 145°C for 4.5 min (7) . In vitro lipid displacement assay. His-tagged Mdm12 (Mdm12-His 6 ) purified from E. coli was incubated with a twofold molar excess of the fluorescent phospholipid NBD-PE (Avanti Polar Lipids) for 2 h on ice. To remove excess unbound NBD-PE, Mdm12-His 6 was bound to an Ni-NTA spin column (Qiagen) and washed twice with ∼500 μL of wash buffer [25 mM imidazole (pH 7.5), 10 mM Hepes (pH 7.5), and 250 mM NaCl]. The Mdm12-His 6 / NBD-PE complex was eluted with 200 μL of elution buffer [250 mM imidazole (pH 7.5), 250 mM NaCl, 10 mM Hepes (pH 7.5)] and further dialyzed against 1 L of buffer [250 mM NaCl and 10 mM Hepes (pH 7.5)] for 1 h at 4°C using a 10,000 molecular weight cut-off (MWCO) Slide-A-Lyzer dialysis cassette (Thermo Scientific). Mdm12-His 6 was quantified and concentrated to a final concentration of ∼1.7 mg/mL for the lipidbinding and competition assay. NBD-PE binding to Mdm12 was assessed by BN-PAGE followed by Coomassie staining and fluorescence detection (extinction/emission, 460 nm/535 nm) for quantification using an ImageQuant LAS4000 molecular imager (GE Healthcare). In a 20-μL reaction, Mdm12-His 6 preloaded with NBD-PE (10 μL at ∼1.7 mg/mL) was mixed with 9 μL of buffer [250 mM NaCl and 10 mM Hepes (pH 7.5)] and 1 μL of 10-mM competitor phospholipid resuspended in methanol. The final protein:lipid concentration ratio in the reaction is 0.028 mM:0.5 mM (∼18fold excess of phospholipid). A lipid-only control (19 μL of buffer and 1 μL NBD-PE 10 mM stock) and protein-only control (10 μL of Mdm12-His 6 preloaded with NBD-PE at ∼1.7 mg/mL incubated with 1 μL of methanol plus 9 μL of buffer) also were included in the assay. The reactions were incubated on ice for 1 h and analyzed by BN-PAGE followed by Coomassie staining and fluorescence detection (extinction/emission 460 nm/535 nm) for quantification using an ImageQuant LAS4000 bimolecular imager. Each experiment was performed in triplicate.
All solvents used for HPTLC were purchased from Merck (HPLC grade). Phospholipids used as HPTLC standards and in the competition assay were purchased from Avanti Polar Lipids: E. coli (bacterial) total lipid extract, S. cerevisiae (yeast) total lipid extract, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (PS), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (PE), 1,2-dioleoyl-sn-glycero-3-phosphocholine (PC), L-α-phosphatidic acid (PA), E. coli L-α-phosphatidylglycerol (PG), E. coli cardiolipin (CL), and L-α-phosphatidylinositol (PI). The lipids were dried under nitrogen and resuspended in methanol at a final concentration of 10 mM. The resulting displacements are shown in Fig. S7D . In vitro lipid displacement assay in the presence of detergent. NBD-PE preloaded Mdm12-His 6 was prepared as described above before being incubated with six distinct detergents present at twice their critical CMC: Triton X-100 [TX100, CMC = 0.01% (wt/vol) = 0.15 mM]; n-Dodecyl β-d-maltoside (DDM; CMC = 0.12 mM); CHAPS (CMC = 8 mM); LDAO (CMC = 0.14 mM); foscholine-14 (FC14; CMC = 0.12 mM); and LFC10 (CMC = 3.2 mM) to quantify the effect of detergent on the binding of the fluorescent lipid. The reactions were incubated on ice for 1 h and analyzed by BN-PAGE followed by Coomassie staining and fluorescence detection for quantification ( Fig. S7A ). Mdm12-His 6 preloading with NBD-PE also was performed in the presence of the same six distinct detergents present at twice their respective CMCs to quantify the effect of detergent on fluorescent lipid preloading.
After loading in presence of detergent, excess unbound NBD-PE was removed by dialysis, and reactions were analyzed by BN-PAGE followed by Coomassie staining and fluorescence detection for quantification ( Fig. S7B ). All detergents were purchased from Anatrace, and the reported CMCs are referenced or determined by Anatrace (Fig. S7C) . LDAO was the best candidate detergent: It enhanced NBD-PE preloading 2.7-fold ( Fig.  S7A ) but did not displace it (<10% loss) ( Fig. S7B) ; thus it facilitates binding but does not displace NBD-PE. For the final lipid displacement reported in Fig. 5C , Mdm12-His was preloaded with NBD-PE in presence of LDAO (0.2 mM, 2× CMC) and then was incubated in the presence of the specific competitor phospholipids solubilized in the presence of LDAO (0.2 mM, 2× CMC) to measure displacement. In vitro lipid transfer assay from liposomes. Yeast total lipid extract (7.5 mg) or yeast total polar lipid extract (5 mg) dissolved in chloroform was gently dried under a stream of N 2. The resulting lipid film was hydrated with 800 μL of 200 mM NaCl, 20 mM Tris (pH 7.5) and filtered to 400-nm liposomes using an extruder (Avanti Polar Lipids) to reach total lipid concentrations of ∼9.4 mg/mL (equivalent to ∼2.3 mM PC) and ∼6.25 mg/mL (equivalent to ∼2.4 mM PC), respectively. For lipid transfer experiments, the pure His-tagged Mdm12, MBP-Mmm1Δ5, or Mdm12/ Mmm1Δ5 complex was concentrated to 0.5 mM, 0.5 mM, or 0.125 mM, respectively. Then 75 μL of each was incubated with 75 μL of either yeast total lipid or yeast total polar lipid liposomes. The reactions were incubated at room temperature for 1 h to enable lipid exchange and transfer from the liposome to the protein. Proteins then were purified on Ni-NTA spin columns (Thermo Fisher). The bound proteins were washed extensively (3 × 500 μL) with wash buffer [25 mM imidazole, 20 mM Tris (pH 7.5), and 300 mM NaCl] to remove unbound lipids and liposomes and were eluted with 400 μL elution buffer [500 mM imidazole, 20 mM Tris (pH 7.5), and 300 mM NaCl]. The resulting eluate was subjected to a Bligh and Dyer (5) extraction as previously described. The organic phase (bottom layer) was recovered and analyzed by HPTLC. Similarly, a liposome background control consisting of an identical amount of liposomes incubated with buffer but no protein also was subjected to Ni-NTA purification and lipid extraction before HPTLC analysis; under these conditions, no liposome carryover was observed in the final eluate ( Fig. 6C ). BN-PAGE and clear native PAGE. BN-PAGE was performed using Bis-Tris 4-16% acrylamide gradient gels (Invitrogen Life Sciences). The anode (lower) buffer system was 50 mM BisTris/50 mM Tricine at pH 6.8. The cathode (upper) buffer system was 50 mM Bis-Tris/50 mM Tricine at pH 6.8 with 0.002% Coomassie G-250 blue dye. For clear native PAGE (CN-PAGE), no Coomassie G-250 blue dye was added in the cathode buffer. Gels were run first at 150 V for 60 min and then at 250 V for 50 min at 4°C. Mdm12 was analyzed by BN-PAGE; MBP-Mmm1Δ5 and Mdm12/ Mmm1Δ5 were analyzed by CN-PAGE.
MS Analyses.
Native MS. Purified protein samples were further desalted with a Vivaspin 10,000 MWCO centrifugal filter device (GE Healthcare) to exchange the initial buffer with 20 mM ammonium acetate at pH 6.8 and to eliminate eventual contaminating small molecules and minimize the amount of protein-salt adducts. Native MS experiments were performed on a 15-T Bruker SolariX Fourier transform ion cyclotron resonance (FTICR) mass spectrometer and a Waters SynaptG1 quadrupole TOF (QTOF) mass spectrometer. Briefly, the protein samples were prepared in 20-50 mM NH 4 OAc solutions at a final concentration of 20 μM. The protein solutions were loaded into a nano-ESI source with Au/Pd coating on a borosilicate emitter (Thermo Scientific) and were electro-sprayed at 1-1.2 kV with a flow rate of 30-50 nL/min. The capillary temperature was set at 120°C. For Fourier transform (FT)-MS, the estimated resolving power was 400,000 at 400 m/z. FT-MS data were processed with DataAnalysis (Bruker Daltonics) and BioTools software and were annotated manually for accurate ion assignment. QTOF data were processed using MassLynx software and deconvoluted with MaxEnt1. ESI-MS/MS quantitative lipid profiling. An automated ESI-MS/MS approach was used, and data acquisition and analysis were carried out as described previously (8) , with modifications. The lipid samples were dissolved in 1 mL chloroform. An aliquot of 15-150 μL of extract in chloroform was used. Precise amounts of internal standards, obtained and quantified as previously described (9) , were added in the following quantities (with some small variations in amounts in different batches of internal standards): 0. The collision gas pressure was set at 2 (arbitrary units). The collision energies, with nitrogen in the collision cell, were +28 V for PE (and lysoPE); +40 V for PC (and lysoPC), PI, and PS; and +20 V for PG. Declustering potentials were +100 V for all positive-mode scans. Entrance potentials were +15 V for PE and +14 V for PC, PG, PI, and PS. Exit potentials were +11 V for PE and +14 V for PC, PG, PI, and PS. The scan speed was 50 or 100 u/s. The mass analyzers were adjusted to a resolution of 0.7 u full width at half height. For each spectrum, 9-150 continuum scans were averaged in multiple channel analyzer (MCA) mode. The source temperature (heated nebulizer) was 100°C, the interface heater was on, +5.5 kV was applied to the electrospray capillary, the curtain gas was set at 20 (arbitrary units), and the two ion source gases were set at 45 (arbitrary units). The background of each spectrum was subtracted, the data were smoothed and peak areas were integrated using a custom script and Applied Biosystems Analyst software, and the data were corrected for overlap of isotopic variants (A + two peaks). A mass spectrum was acquired only on the internal standard mixture. Peaks corresponding to the target lipids in this spectrum were identified, and molar amounts were calculated in comparison with the two internal standards on the same lipid class. To correct for chemical or instrumental noise in the samples, the molar amount of each lipid metabolite detected in the internal-standards-only spectrum was subtracted from the molar amount of each metabolite calculated in each set of sample spectra. Finally, the data were corrected for the fraction of the sample analyzed, and the amount of each lipid species was divided by the total (× 100) to calculate molar percentage. Samples used for EM were purified as described previously with a final SEC purification performed in 50 mM NaCl, 20 mM Tris (pH 7.8). For negative-stain EM, a 2-μL sample was applied to a glow-discharged grid that was covered with carbon film. After 30-s incubation, the sample was blotted with filter paper and stained with 0.8% uranyl formate. EM micrographs were recorded on a TIETZ F415MP 16-megapixel CCD camera at 68,027× calibrated magnification in an FEI Tecnai F20 electron microscope operated at 200 kV. The micrographs were saved by 2× binning, yielding a pixel size of 4.41 Å. Image acquisition was performed with the assistance of Leginon automation software (10, 11) . For RCT 3D reconstruction of Mdm12/Mmm1Δ5, micrographs were collected with the grids tilted at two angles successively (65°and 0°) for each specimen area of interest. For the other samples, micrographs were collected without tilting the grids. For RCT 3D reconstructions, corresponding particles (80 × 80 pixels) from each pair of tilted and untilted micrographs were picked using ApTiltPicker.py in Appion (12) . To avoid bias in particle picking, all possible particles were picked for the following image classification. The defocus values of 0°-tilted and 65°-tilted micrographs were calculated by CTFFIND and CTFTILT programs (13), respectively. The phase flipping was performed on particle images before classification and 3D reconstructions. The 0°-tilted particles were classified using the Correspondence Analysis method in SPIDER (14) . After classification, each class of 65°-tilted particles was subjected to 3D reconstruction using the Euler angles from both the geometrical relationship between the 65°-tilted and 0°-tilted images and the in-plane rotation alignment of the 0°-tilted images. The 3D RCT maps then were refined iteratively using the 65°-tilted particles with SPIDER by refinement of particle centers. No symmetry was applied during RCT 3D reconstruction and refinement. A representative 3D RCT map of Mdm12/Mmm1Δ5 was reconstructed at 35-Å resolution from 1,493 particles.
For 2D classification and 3D reconstruction of untilted images, particles (80 × 80 pixels) were picked automatically from micrographs using ApDogPicker.py in Appion. The phase flipping was performed on particle images using the defocus values estimated by CTFFIND. The 2D classification was performed using refine2d.py in EMAN (15) . The 3D reconstruction and refinement of Mdm12/Mmm1Δ1 were carried out with EMAN using the 3D RCT map of Mdm12/Mmm1Δ5 as the starting model. Twofold symmetry was applied in the 3D refinement. The 3D map of Mdm12/Mmm1Δ1 was reconstructed at 17-Å resolution using 94,516 particles.
Molecular modeling and rigid body fitting were performed with COOT (16) and Chimera (17) for the final analysis, modeling, and rendering of the EM maps and complexes reconstructed by EM. The structures in the ribbon diagram are shown in the same relative orientation with a bound phospholipid (PL) modeled. L1 (between strands β2 and β3) and L2 (between strands β5 and β6) correspond to the nonconserved insertions present in S. cerevisiae but not in D. discoideum. Residues with the highest degree of sequence conservation are represented by spheres. (B) Best structural templates identified by Phyre 2 for homology modeling. Template PDB is the crystal structure from the PDB used for sequence alignment and structure prediction by homology modeling. Residues modeled correspond to the region of the target protein (Mdm12 or Mmm1Δ5) that was modeled using the template structure from the PDB. % Sequence identity indicates the sequence identity between the query (Mdm12 or Mmm1Δ5) and the template PDB structure used for homology modeling. The model of Mdm12 has a 99.7% confidence score, with 67% of residues between residues W7 and G269 modeled at greater than 90% confidence. The model of Mmm1 has a confidence score of 100%, with 73% of the residues between residues S197 and S415 modeled at greater than 90% confidence. PDB ID codes: 1EWF and 1BP1, bactericidal permeability increase protein (2); 2OBD, cholesteryl ester transfer protein (3); 4M4D, lipopolysaccharide-binding protein (4). The most abundant phospholipid species are in bold.
